These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

84 related articles for article (PubMed ID: 7428062)

  • 41. Fetal cardiac output, distribution to the placenta and impact of placental compromise.
    Kiserud T; Ebbing C; Kessler J; Rasmussen S
    Ultrasound Obstet Gynecol; 2006 Aug; 28(2):126-36. PubMed ID: 16826560
    [TBL] [Abstract][Full Text] [Related]  

  • 42. [Chronic and acute effect of cycletanine in NO-dependent hypertensive pregnant rats].
    Van Overloop B; Pernot F; Dité C; Droy-Lefaix MT; Gairard A
    Arch Mal Coeur Vaiss; 1995 Aug; 88(8):1223-7. PubMed ID: 8572878
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Pregnancy and progeny in rats treated with prostaglandin F1 alpha.
    Persaud TV
    Prostaglandins Med; 1980 Feb; 4(2):101-6. PubMed ID: 7394052
    [TBL] [Abstract][Full Text] [Related]  

  • 44. The role of the placenta in intrauterine growth restriction (IUGR).
    Cetin I; Antonazzo P
    Z Geburtshilfe Neonatol; 2009 Jun; 213(3):84-8. PubMed ID: 19536707
    [TBL] [Abstract][Full Text] [Related]  

  • 45. The fetal response to chronic placental insufficiency.
    Neerhof MG; Thaete LG
    Semin Perinatol; 2008 Jun; 32(3):201-5. PubMed ID: 18482622
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Angiogenesis and intrauterine growth restriction.
    Ahmed A; Perkins J
    Baillieres Best Pract Res Clin Obstet Gynaecol; 2000 Dec; 14(6):981-98. PubMed ID: 11141345
    [TBL] [Abstract][Full Text] [Related]  

  • 47. In utero perfusing fraction maps in normal and growth restricted pregnancy measured using IVIM echo-planar MRI.
    Moore RJ; Strachan BK; Tyler DJ; Duncan KR; Baker PN; Worthington BS; Johnson IR; Gowland PA
    Placenta; 2000 Sep; 21(7):726-32. PubMed ID: 10985977
    [TBL] [Abstract][Full Text] [Related]  

  • 48. [New approaches in the treatment of hypotrophic fetuses].
    Burnog T; Pilka L; Roztocil A; Malý Z
    Cesk Gynekol; 1993 Sep; 58(4):171-5. PubMed ID: 8402976
    [TBL] [Abstract][Full Text] [Related]  

  • 49. The effect of a mast cell degranulating agent on vascular resistance in the human placental vascular bed and on the tone of isolated placental vessels.
    Bytautiene E; Vedernikov YP; Saade GR; Romero R; Garfield RE
    Reprod Sci; 2008 Jan; 15(1):26-32. PubMed ID: 18212351
    [TBL] [Abstract][Full Text] [Related]  

  • 50. [Studies of synthetic contraceptives. III. Stereospecific total synthesis of racemic prostaglandin F2 alpha (author's transl)].
    Han GD; Yang GZ; Zhu LY; Zheng DK; Wang ZR; Li YH; Ruan SJ; Li ZY; Qin YC; Fan RL; Chu JY; Wu DJ; Wang FY
    Yao Xue Xue Bao; 1981 Feb; 16(2):114-21. PubMed ID: 7304177
    [No Abstract]   [Full Text] [Related]  

  • 51. [Pregnancy complications can impair placental transport systems. Aberrant fetal growth, for example in diabetes, is only now beginning to be understood].
    Jansson T; Wennergren M; Powell T
    Lakartidningen; 2003 Aug; 100(32-33):2508-11. PubMed ID: 12959009
    [TBL] [Abstract][Full Text] [Related]  

  • 52. [Inactivation of prostaglandin F2 alpha in pulmonary and systemic circulation (author's transl)].
    Chijimatsu Y; Takahashi Y; Tamura M; Homma H
    Kokyu To Junkan; 1980 Aug; 28(8):885-9. PubMed ID: 7209142
    [No Abstract]   [Full Text] [Related]  

  • 53. [Researches on prostanoids. I. Total synthesis of DL-prostaglandin F2 alpha and its omega-ethyl analog (author's transl)].
    Wu YL; Zhu LY; Yang GZ; Zheng DK; Shao GX; Chen JM; Han GD; Jin BY; Zhang YH; Jin XF; Tian HZ; Wu HY
    Yao Xue Xue Bao; 1981 May; 16(5):349-55. PubMed ID: 7246180
    [No Abstract]   [Full Text] [Related]  

  • 54. [Responsiveness of the isolated canine ciliary artery to several vasoactive substances (author's transl)].
    Shimizu Y; Chiba S
    Nippon Ganka Gakkai Zasshi; 1981 Oct; 85(10):1772-7. PubMed ID: 6121477
    [No Abstract]   [Full Text] [Related]  

  • 55. [Investigations for the measurement of placental blood flow (author's transl)].
    Dietzsch R; Gursky S
    Radiol Diagn (Berl); 1978 Aug; 19(4):537-45. PubMed ID: 734103
    [No Abstract]   [Full Text] [Related]  

  • 56. [Prenatal treatment of a hypotrophic foetus by long-term glucose infusions. II. Changes of the parameters studied during the course of prenatal treatment (author's transl)].
    Sabata V; Stembera Z; Zidovský J; Bukovský A; Jungmannová C
    Cesk Gynekol; 1980 Jul; 45(6):379-83. PubMed ID: 7428060
    [No Abstract]   [Full Text] [Related]  

  • 57. [Antiserum reaction to prostaglandin F2 alpha with modified prostaglandins F2].
    Bezuglov VV; Gromova NV; Bassalyk LS; Shevchenko VP; Miasoedov NF
    Dokl Akad Nauk SSSR; 1980; 255(4):999-1002. PubMed ID: 7215136
    [No Abstract]   [Full Text] [Related]  

  • 58. Fetal nutrition and brain growth.
    Winick M
    Ann N Y Acad Sci; 1986; 477():194-5. PubMed ID: 3468825
    [No Abstract]   [Full Text] [Related]  

  • 59. [The effect of prostaglandin PGF2-alpha on heart function].
    Sterio D; Grujić N; Filipović D; Lazetić B; Bajić M
    Med Pregl; 1982; 35(1-2):15-21. PubMed ID: 6956792
    [No Abstract]   [Full Text] [Related]  

  • 60. Effect of prostaglandin F2 alpha on the bovine fetal ruminal wall in vitro.
    Arias JL; Zurich L; Gonzalez CM
    Vet Res Commun; 1981 Dec; 5(2):151-8. PubMed ID: 7345724
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 5.